Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Pilot who wrote (648)	1/8/1998 12:01:00 AM
From: Amigo Mike	Read Replies (3) \| Respond to of 1476

Gee Pilot, That was 4 months ago on the 56 thread. You go back and read that ??? I am flattered that one post sticks out so much. I had to go a read it myself to see what I said. I have reviewed the small cap listing requirements many times over the last few years keeping up to date. Antex fulfills all listing requirements with the exception of the share price. Pilot, you mentioned a reverse split ..... I have previously suggested that to Antex during the past year and all they would say is that it is an option to consider. I personally would welcome it as .... in my mind .... it would accomplish the required share price for listing, significantly reduce the outstanding shares AND also the possibility for real brokerage coverage plus IMO reduce the effects of possible Bliar exercises. I would very much like to see a 1 for 5 reverse split right now. I could see Antex becoming another MDRX very easily. Back to that August post..... well the SKB stuff has passed ... all three trial results (all should be favorable) are due very shortly as confirmed by Chris's post. I'm sure Antex has another developement or two to pass along to us in the 1st qtr. Mike